Literature DB >> 1544914

In vitro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron.

T A Cooper1.   

Abstract

A single cardiac troponin T (cTNT) gene generates two mRNAs by including or excluding the 30-nucleotide exon 5 during pre-mRNA processing. Transfection analysis of cTNT minigenes has previously demonstrated that both mRNAs are expressed from unmodified minigenes, and mutations within exon 5 can lead to complete skipping of the exon. These results suggested a role for exon sequence in splice site recognition. To investigate this potential role, an in vitro splicing system using cTNT precursors has been established. Two-exon precursors containing the alternative exon and either the upstream exon or downstream exon were spliced accurately and efficiently in vitro. The mutations within the alternative exon that resulted in exon skipping in vivo specifically blocked splicing of the upstream intron in vitro and had no effect on removal of the downstream intron. In addition, the splicing intermediates of these two precursors have been characterized, and the branch sites utilized on the introns flanking the alternative exon have been determined. Potential roles of exon sequence in splice site selection are discussed. These results establish a system that will be useful for the biochemical characterization of the role of exon sequence in splice site selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Splicing enhancement in the yeast rp51b intron.

Authors:  D Libri; A Lescure; M Rosbash
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

2.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

Authors:  M P Wentz; B E Moore; M W Cloyd; S M Berget; L A Donehower
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  The role of evolutionarily conserved sequences in alternative splicing at the 3' end of Drosophila melanogaster myosin heavy chain RNA.

Authors:  D Hodges; R M Cripps; M E O'Connor; S I Bernstein
Journal:  Genetics       Date:  1999-01       Impact factor: 4.562

4.  SR proteins are sufficient for exon bridging across an intron.

Authors:  J M Stark; D P Bazett-Jones; M Herfort; M B Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.

Authors:  J M Yeakley; J P Morfin; M G Rosenfeld; X D Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  A short sequence within two purine-rich enhancers determines 5' splice site specificity.

Authors:  L L Elrick; M B Humphrey; T A Cooper; S M Berget
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.

Authors:  A N Ladd; N Charlet; T A Cooper
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

8.  Molecular genetic dissection of mouse unconventional myosin-VA: tail region mutations.

Authors:  J D Huang; V Mermall; M C Strobel; L B Russell; M S Mooseker; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

9.  Selection of novel exon recognition elements from a pool of random sequences.

Authors:  H Tian; R Kole
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.

Authors:  B A Amendt; D Hesslein; L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.